These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21628706)

  • 21. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions.
    Fernández-Serrano MJ; Pérez-García M; Schmidt Río-Valle J; Verdejo-García A
    J Psychopharmacol; 2010 Sep; 24(9):1317-32. PubMed ID: 20007413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct cognitive performance and patterns of drug use among early and late onset cocaine users.
    Lopes BM; Gonçalves PD; Ometto M; Dos Santos B; Cavallet M; Chaim-Avancini TM; Serpa MH; Nicastri S; Malbergier A; Busatto GF; de Andrade AG; Cunha PJ
    Addict Behav; 2017 Oct; 73():41-47. PubMed ID: 28475942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive functioning of adolescent and young adult cannabis users in the Philadelphia Neurodevelopmental Cohort.
    Scott JC; Wolf DH; Calkins ME; Bach EC; Weidner J; Ruparel K; Moore TM; Jones JD; Jackson CT; Gur RE; Gur RC
    Psychol Addict Behav; 2017 Jun; 31(4):423-434. PubMed ID: 28414475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
    Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use.
    Coulston CM; Perdices M; Tennant CC
    Schizophr Res; 2007 Nov; 96(1-3):169-84. PubMed ID: 17826035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
    Piechatzek M; Indlekofer F; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    Hum Psychopharmacol; 2009 Dec; 24(8):650-65. PubMed ID: 19946940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between non-acute adolescent cannabis use and cognition.
    Harvey MA; Sellman JD; Porter RJ; Frampton CM
    Drug Alcohol Rev; 2007 May; 26(3):309-19. PubMed ID: 17454021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research.
    Jager G; Ramsey NF
    Curr Drug Abuse Rev; 2008 Jun; 1(2):114-23. PubMed ID: 19630711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes in cognition in young adult cannabis users.
    Becker MP; Collins PF; Schultz A; Urošević S; Schmaling B; Luciana M
    J Clin Exp Neuropsychol; 2018 Aug; 40(6):529-543. PubMed ID: 29058519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.
    Gonzalez R
    Neuropsychol Rev; 2007 Sep; 17(3):347-61. PubMed ID: 17680367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE; Martin-Iverson MT
    Psychol Med; 2010 Oct; 40(10):1635-46. PubMed ID: 20018124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Executive attention impairment in adolescents with schizophrenia who have used cannabis.
    Epstein KA; Kumra S
    Schizophr Res; 2014 Aug; 157(1-3):48-54. PubMed ID: 24875171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study.
    Meier MH; Caspi A; Danese A; Fisher HL; Houts R; Arseneault L; Moffitt TE
    Addiction; 2018 Feb; 113(2):257-265. PubMed ID: 28734078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use and cognitive functioning in first-episode schizophrenia patients.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Mata I; Moreno-Calle T; Perez-Iglesias R; González-Blanch C; Periañez JA; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Dec; 124(1-3):142-51. PubMed ID: 20826079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
    Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
    Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological performance in young adults with cannabis use disorder.
    Selamoglu A; Langley C; Crean R; Savulich G; Cormack F; Sahakian BJ; Mason B
    J Psychopharmacol; 2021 Nov; 35(11):1349-1355. PubMed ID: 34694178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers.
    de la Serna E; Mayoral M; Baeza I; Arango C; Andrés P; Bombin I; González C; Rapado M; Robles O; Rodríguez-Sánchez JM; Zabala A; Castro-Fornieles J
    J Nerv Ment Dis; 2010 Feb; 198(2):159-62. PubMed ID: 20145493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.